NASDAQ
03.12.24
16:44 Uhr
0,840 US-Dollar
+0,030
+3,70 %
+3,70 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 26.11. | IceCure Medical GAAP EPS of $0.22 , revenue of $2.41M | 1 | Seeking Alpha | ||
| 26.11. | IceCure Medical reports 36% sales growth in first nine months of 2024 | 1 | Seeking Alpha | ||
| 26.11. | Icecure Medical Earnings Review: Q3 Summary | 1 | Benzinga.com | ||
| 26.11. | IceCure Medical Reports 36% Sales Growth in the First Nine Months of 2024 Driven by Global Adoption of ProSense Cryoablation | 101 | PR Newswire | FDA Marketing Authorization Decision on Early Stage-Low Risk Breast Cancer Expected in Q1 2025
Conference call to be held today at 10:00 am Eastern Time
CAESAREA... ► Artikel lesen | |
| 25.11. | What to Expect from Icecure Medical's Earnings | 1 | Benzinga.com | ||
| 25.11. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 08.11. | IceCure gets favorable FDA AdCom vote for ProSense System | 2 | Seeking Alpha | ||
| 08.11. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| ICECURE MEDICAL Aktie jetzt für 0€ handeln | |||||
| 05.11. | IceCure Medical Ltd. - F-1/A, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 21.10. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 21.10. | IceCure Medical: IceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation System | 65 | PR Newswire | Innovative cryogenic system connector technology designed to improve usability and maintain the integrity of cryogen used in the cryoablation procedure
CAESAREA, Israel, Oct. 21, 2024 /PRNewswire/... ► Artikel lesen | |
| 15.10. | IceCure Medical Ltd. - F-1, Registration statement for certain foreign private issuers | 1 | SEC Filings | ||
| 08.10. | ICCM-Aktie erreicht 52-Wochen-Tief bei 0,48 US-Dollar | 3 | Investing.com Deutsch | ||
| 08.10. | ICCM stock touches 52-week low at $0.48 amid market challenges | 1 | Investing.com | ||
| 07.10. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 24.09. | IceCure reports high success rate in breast cancer trial | 1 | Investing.com | ||
| 24.09. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 12.09. | FDA AdComm to discuss IceCure's ProSense on Nov. 7 | 1 | Seeking Alpha | ||
| 12.09. | IceCure Medical Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 28.08. | IceCure expands patent portfolio with USPTO allowance | 1 | Investing.com |
Seite:
1 2 3 Weiter >>
48 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| EMEIS | 5,483 | -1,33 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| NANO-X IMAGING | 6,110 | -6,22 % | Nano-X Imaging Ltd. (NNOX): A Bear Case Theory | ||
| BUTTERFLY NETWORK | 3,305 | -1,93 % | Butterfly Network Reports Third Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with portable, semiconductor-based... ► Artikel lesen | |
| GOODRX | 4,835 | -2,52 % | Pennsylvania pharmacies seek to centralize GoodRx antitrust claims in Rhode Island | ||
| TALKSPACE | 3,445 | -0,72 % | Espresa Partners with Talkspace to Boost Employee Well-Being with Accessible Mental Health Benefits | Espresa has partnered with Talkspace to expand mental health support for employees. Through Espresa's platform, clients now have access to Talkspace's 5,000+ licensed therapists, offering secure, on-demand... ► Artikel lesen | |
| CARMAT | 1,098 | -4,69 % | Successful first "Aeson European User Meeting", marking an important step in the deployment of CARMAT's artificial heart | More than 100 healthcare professionals from 41 hospitals and 10 countries rallied to share their experiences of the Aeson® artificial heart All hospitals taking part in the event confirmed... ► Artikel lesen | |
| JOINT CORP | 11,560 | -1,37 % | The Joint Corp. to Participate in the 13th Annual ROTH Deer Valley Event | ||
| MIMEDX | 9,420 | +0,43 % | MiMedx Group Stock Soars to 52-Week High of $9.62 | ||
| HYPERFINE | 1,000 | 0,00 % | Hyperfine, Inc. Reports Third Quarter 2024 Financial Results | GUILFORD, Connecticut, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 94,24 | -1,88 % | 5 Analysts Assess PROCEPT BioRobotics: What You Need To Know | ||
| BIOMERICA | 0,370 | -10,15 % | Biomerica, Inc.: Nasdaq grants Biomerica an additional 180 days to meet listing compliance requirements | IRVINE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), a leading global provider of advanced medical diagnostics, announced that it has been granted an additional 180-day... ► Artikel lesen | |
| PROGYNY | 15,210 | -2,44 % | Here's What Led to a Sharp Drop in Progyny's (PGNY) Share Price | ||
| ATRICURE | 36,570 | -1,35 % | Pre-market Movers: ASP Isotopes, NerdWallet, Reddit, AtriCure, Qorvo | OLATHE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green ASP Isotopes Inc. (ASPI) is up over 44% at $8.33.
NerdWallet... ► Artikel lesen | |
| LIFEMD | 6,150 | -6,39 % | LifeMD, Inc.: LifeMD Reports Third Quarter 2024 Results | Total revenues increased 38% year-over-year to $53.4 million with telehealth revenue up 65%Record gross margin of 90.6%, up 300 basis points from the year-ago periodAdjusted EBITDA increased 33% to... ► Artikel lesen | |
| PROPHASE LABS | 0,715 | 0,00 % | ProPhase Labs, Inc.: ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025 | Projections for Pharmaloz Manufacturing: Approximately $16-17 Million in Revenue, $6-7 Million in Pre-Tax Earnings for 2025 Strategic Partnership Discussions Begin for BE-Smart Esophageal Cancer... ► Artikel lesen |
ICECURE MEDICAL LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +3,70 % bei einem Aktienkurs von 0,840 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ICECURE MEDICAL LTD finden Sie auf Wallstreet Online.
